FAKTOR-OPTIONSSCHEIN - BRISTOL-MYERS SQUIBB | Market Closed - Deutsche Boerse AG 03:40:01 2024-06-04 pm EDT | ||
| 56.55 EUR | +2.22% |
|
| Current month | -8.64% | ||
| 1 month | +18.50% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Latest news about BRISTOL-MYERS SQUIBB COMPANY
More news
| Date | Price | Change |
|---|---|---|
| 24-06-04 | 56.55 | +2.22% |
| 24-06-03 | 55.32 | -10.63% |
| 24-05-31 | 61.9 | -5.24% |
| 24-05-30 | 65.32 | +0.31% |
| 24-05-29 | 65.12 | +1.39% |
Delayed Quote Deutsche Boerse AG
Last update June 04, 2024 at 03:40 pm EDT
More quotesStatic data
| Product type | Exotic Products |
|---|---|
| Buy / Sell | CALL |
| Underlying | BRISTOL-MYERS SQUIBB COMPANY |
| Issuer | 
Société Générale
|
| WKN | SQ3K53 |
| ISIN | DE000SQ3K533 |
| Date issued | 2022-10-31 |
| Strike | 74.34 $ |
| Maturity | Unlimited |
| Parity | 1 : 1 |
| Emission price | 10.13 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 67.4 € |
|---|---|
| Lowest since issue | 7.36 € |
| Spread | 1.32 € |
| Spread % | 2.17% |
Company Profile
Bristol-Myers Squibb Company est spécialisé dans le développement, la fabrication et la commercialisation de produits pharmaceutiques. Les produits sont destinés au traitement des cancers, des maladies cardio-vasculaires, de l'hépatite, des maladies immunitaires et des désordres psychiatriques.
The United States account for 70.1% of net sales.
Sector
-
Ratings for Bristol-Myers Squibb Company
Trading Rating
Investor Rating
ESG Refinitiv
B
Consensus: Bristol-Myers Squibb Company
Sell
Buy
Mean consensus
HOLD
Number of Analysts
26
Last Close Price
41.75
USD
Average target price
53.19
USD
Spread / Average Target
+27.41%
- Stock Market
- Certificates
- Certificat
